JAMA Oncology Author Interviews - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

JAMA Oncology Author Interviews — Health & Fitness
JAMA Oncology Author Interviews

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Latest Episodes:

Tailoring Intensity of Surveillance for Prostate Cancer Based on Prediction of Risk Stability Aug 27, 2020

Show notes

Interview with Matthew R. Cooperberg, MD MPH, author of Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability

Presence of ctDNA and CTCs After Chemotherapy and Recurrence of Triple-Negative Breast Cancer Jul 09, 2020

Show notes

Interview with Bryan P. Schneider, MD, and Milan Radovich, PhD, authors of Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults Jun 18, 2020

Show notes

Interview with Susan C. Gilchrist, MD, MS, author of Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults

Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases Jun 04, 2020

Show notes

Interview with Chad G. Rusthoven, MD, author of Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer Apr 16, 2020

Show notes

Interview with Charles Dolladille, MD, author of Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy for Metastatic NSCLC Apr 09, 2020

Show notes

Interview with Naiyer A. Rizvi, MD, author of Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer Feb 13, 2020

Show notes

Interview with Nima Sharifi, M.D., author of HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Cost Transparency for Prostate Cancer Radiation Therapy at National Cancer Institute–Designated Cancer Centers Jan 16, 2020

Show notes

Interview with Trevor J. Royce, MD MS MPH, author of Analysis of Price Transparency via National Cancer Institute–Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy

Association Between BMI and Overall Survival in Advanced Non–Small Cell Lung Cancer Dec 26, 2019

Show notes

Interview with Ganessan Kichenadasse, MBBS, FRACP, author of Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

The Role of Maintenance Strategies in Metastatic Colorectal Cancer Dec 19, 2019

Show notes

Interview with Mohamad Bassam Sonbol, M.D., author of The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Related Podcasts